Journal of Urologic Oncology

Editorial

July 31, 2024

Summarizing the Intentions and Outcomes of Journal of Urologic Oncology 2024 Issue 2

Cheol Kwak

J Urol Oncol. 2024;22(2):97-99.

Invited Review

July 31, 2024

A Narrative Review on Systemic Therapy for Renal Cell Carcinoma in the Perioperative Setting

Isamu Tachibana, Qian Qin, Jacob Taylor, et al.

J Urol Oncol. 2024;22(2):100-104.

In patients with renal cell carcinoma (RCC), the use of immunotherapy (IO) and tyrosine kinase inhibitor (TKI) regimens has proven beneficial in treating metastatic disease. These advances have led to...

Invited Review

July 31, 2024

Robot-Assisted Radical Nephrectomy With Inferior Vena Cava Thrombectomy: A Narrative Review With Step-by-Step Procedures

Seokhwan Bang, Sung-Hoo Hong

J Urol Oncol. 2024;22(2):105-114.

Inferior vena cava (IVC) thrombi are detected in 4%–10% of patients with renal cell carcinoma (RCC). The 5-year survival rates following radical nephrectomy (RN) with IVC thrombectomy for patients with...

Invited Review

July 31, 2024

Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians

Bokyung Ahn, Jinahn Jeong, Yong Il Lee, et al.

J Urol Oncol. 2024;22(2):115-127.

The remarkable advances in our understanding of renal tumor pathogenesis, driven by the widespread application of molecular testing, are reflected in the latest 2022 World Health Organization classification. This updated...

Original Article

July 31, 2024

Diagnostic Accuracy of Contrast-Enhanced Ultrasonography for the Assessment of Small Renal Mass: A Prospective Study

Jae-Wook Chung, Seo Young Park, Seunghee Woo, et al.

J Urol Oncol. 2024;22(2):128-135.

Purpose: We prospectively compared the diagnostic accuracy of kidney dynamic computed tomography (KDCT), magnetic resonance imaging (MRI), and contrast-enhanced ultrasonography (CEUS) for the assessment of small renal mass (SRM) (≤4...

Original Article

July 31, 2024

Comparison of Outcomes Between Radical Nephrectomy and Partial Nephrectomy in Clinical T2 Renal Cell Carcinoma: A Retrospective Korean Renal Cell Carcinoma Cohort Study

Younsoo Chung, Seok-Soo Byun, Sung Kyu Hong, et al.

J Urol Oncol. 2024;22(2):136-143.

Purpose: We compared the surgical outcomes of radical nephrectomy (RN) and partial nephrectomy (PN) in adult patients with clinical T2 stage (cT2) renal cell carcinoma (RCC) by utilizing data from...

Invited Review

July 31, 2024

Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion

Vanessa M. Hayes, Sean M. Patrick, Joyce Shirinde, et al.

J Urol Oncol. 2024;22(2):144-149.

Prostate cancer shows significant racial disparity, with men of African ancestry disproportionately impacted. While prostate cancer health disparity studies focus on elucidating the contributing socioeconomic, lifestyle, environmental, biological and underlying...

Review Article

July 31, 2024

The Integral Role and Clinical Significance of Metabolic Profiling in Prostate Cancer: A Narrative Review

Valentin Nikolaevich Pavlov, Marat Fayazovich Urmantsev, Marat Radikovich Bakeev, et al.

J Urol Oncol. 2024;22(2):150-156.

Prostate cancer (PC) is the most commonly diagnosed malignancy among males worldwide. In recent years, there has been a need to find alternative methods for the early diagnosis of PC....

Original Article

July 31, 2024

Changes in Treatment After Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography in Patients With Prostate Cancer: A Retrospective Case Series Study

Si Hyun Kim, Chang Wook Jeong, Minh-Tung Do, et al.

J Urol Oncol. 2024;22(2):157-165.

Purpose: The use of gallium-68 prostate-specific membrane antigen-11 positron emission tomography/computed tomography (Ga-68 PSMA-11 PET/CT) is becoming increasingly common among men with prostate cancer (PCa). However, it remains uncertain which...

Invited Review

July 31, 2024

The Role of Fibroblast Growth Factor Receptors Inhibitors in Bladder Cancer

Ho Kyung Seo, Eui Hyun Jung, Sora Yang, et al.

J Urol Oncol. 2024;22(2):166-177.

Dysregulation of fibroblast growth factor (FGF)-receptor (FGFR) signaling, which is implicated in various oncogenic processes, including tumor proliferation, survival, migration, invasion, and angiogenesis, has been identified as a critical factor...

Original Article

July 31, 2024

Effects of Neoadjuvant Chemotherapy on Rates of Depression in Muscle Invasive Bladder Cancer

Matthew DeSanto, Frank H. Annie, Stacie Deslich, et al.

J Urol Oncol. 2024;22(2):178-182.

Purpose: The objective of this large retrospective cohort study is to better understand the relationship of bladder cancer and depression incidence, specifically relating to the incorporation of neoadjuvant chemotherapy (NCT)...

Erratum: Correction of Funding Information

July 31, 2024

Erratum: Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy

Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al.

J Urol Oncol. 2024;22(2):183-183.

Summarizing the Intentions and Outcomes of Journal of Urologic Oncology 2024 Issue 2 Cheol Kwak J Urol Oncol. 2024;22(2):97-99. Editorial Jul 31, 2024 Full text PubReader ePub PDF	A Narrative Review on Systemic Therapy for Renal Cell Carcinoma in the Perioperative Setting Isamu Tachibana, Qian Qin, Jacob Taylor, et al. J Urol Oncol. 2024;22(2):100-104. Cited By 1 Invited Review Jul 31, 2024 Renal Cell Carcinoma Full text PubReader ePub PDF
Robot-Assisted Radical Nephrectomy With Inferior Vena Cava Thrombectomy: A Narrative Review With Step-by-Step Procedures Seokhwan Bang, Sung-Hoo Hong J Urol Oncol. 2024;22(2):105-114. Cited By 1 Invited Review Jul 31, 2024 Renal Cell Carcinoma Full text PubReader ePub PDF	Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians Bokyung Ahn, Jinahn Jeong, Yong Il Lee, et al. J Urol Oncol. 2024;22(2):115-127. Cited By 1 Invited Review Jul 31, 2024 Renal Cell Carcinoma Full text PubReader ePub PDF
Diagnostic Accuracy of Contrast-Enhanced Ultrasonography for the Assessment of Small Renal Mass: A Prospective Study Jae-Wook Chung, Seo Young Park, Seunghee Woo, et al. J Urol Oncol. 2024;22(2):128-135. Cited By 1 Original Article Jul 31, 2024 Renal Cell Carcinoma Full text PubReader ePub PDF	Comparison of Outcomes Between Radical Nephrectomy and Partial Nephrectomy in Clinical T2 Renal Cell Carcinoma: A Retrospective Korean Renal Cell Carcinoma Cohort Study Younsoo Chung, Seok-Soo Byun, Sung Kyu Hong, et al. J Urol Oncol. 2024;22(2):136-143. Cited By 1 Original Article Jul 31, 2024 Renal Cell Carcinoma Full text PubReader ePub PDF Supplementary Material
Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion Vanessa M. Hayes, Sean M. Patrick, Joyce Shirinde, et al. J Urol Oncol. 2024;22(2):144-149. Cited By 1 Invited Review Jul 31, 2024 Prostate Cancer Full text PubReader ePub PDF	The Integral Role and Clinical Significance of Metabolic Profiling in Prostate Cancer: A Narrative Review Valentin Nikolaevich Pavlov, Marat Fayazovich Urmantsev, Marat Radikovich Bakeev, et al. J Urol Oncol. 2024;22(2):150-156. Cited By 1 Review Article Jul 31, 2024 Prostate Cancer Full text PubReader ePub PDF
Changes in Treatment After Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography in Patients With Prostate Cancer: A Retrospective Case Series Study Si Hyun Kim, Chang Wook Jeong, Minh-Tung Do, et al. J Urol Oncol. 2024;22(2):157-165. Cited By 1 Original Article Jul 31, 2024 Prostate Cancer Full text PubReader ePub PDF Supplementary Material	The Role of Fibroblast Growth Factor Receptors Inhibitors in Bladder Cancer Ho Kyung Seo, Eui Hyun Jung, Sora Yang, et al. J Urol Oncol. 2024;22(2):166-177. Cited By 1 Invited Review Jul 31, 2024 Bladder Cancer Full text PubReader ePub PDF
Effects of Neoadjuvant Chemotherapy on Rates of Depression in Muscle Invasive Bladder Cancer Matthew DeSanto, Frank H. Annie, Stacie Deslich, et al. J Urol Oncol. 2024;22(2):178-182. Cited By 1 Original Article Jul 31, 2024 Bladder Cancer Full text PubReader ePub PDF	Erratum: Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al. J Urol Oncol. 2024;22(2):183-183. Corrects: J Urol Oncol 2023;21(3):249 Erratum: Correction of Funding Information Jul 31, 2024 Bladder Cancer Full text PubReader ePub PDF

5,615	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,064	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
4,410	The Present and Future of Intravesical Therapy in Bladder Cancer
4,360	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,355	Complex Epidemiology of Prostate Cancer in Asian Countries

Cited By 7	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use